Details of the Drug Reposition

General Information of This Drug (ID: DM2AHXW)

Drug Name	CD171 specific CAR T cells expressing EGFRt DM2AHXW
Drug Type	CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Ganglioneuroblastoma	DIS6FPB6	2A00.11	Phase 1	[1]
Neuroblastoma	DISVZBI4	2D11.2	Phase 1	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02311621) Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01